Medikit Co.,Ltd.

Medikit Co.,Ltd.

7749.T
Medikit Co.,Ltd.JP flagTokyo Stock Exchange
2,796.00
JPY
+6.00
- -
40.48BMarket Cap

Total Valuation

Medikit Co.,Ltd. carries a market capitalization of 40.48B, placing it among publicly traded companies globally. Its enterprise value stands at 19.95B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap40.48B
Enterprise Value19.95B

Share Statistics

Medikit Co.,Ltd. currently has 14.81M shares outstanding.

Shares Outstanding14.81M
Owned by Insiders (%)N/A
Owned by Institutions (%)N/A

Valuation Ratios

Medikit Co.,Ltd. trades at a trailing price-to-earnings ratio of 24.47. The price-to-sales ratio is 3.89, and the price-to-book ratio stands at 1.03.

PE Ratio24.47
PS Ratio3.89
PB Ratio1.03
P/TBV Ratio1.04
P/FCF RatioN/A
P/OCF RatioN/A

Enterprise Valuation

On an enterprise value basis, Medikit Co.,Ltd. trades at an EV/EBITDA multiple of 8.31 and an EV/FCF ratio of 7,088.05. The EV/Sales ratio of 1.81 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 8.31 provides insight into valuation relative to core operating earnings.

EV / Sales1.81
EV / EBITDA8.31
EV / EBIT8.31
EV / FCF7,088.05

Financial Position

Medikit Co.,Ltd. maintains a current ratio of 5.45, meaning it holds 5.5x the short-term assets needed to cover near-term liabilities.

Current Ratio5.45
Quick Ratio3.66
Debt / EquityN/A
Debt / EBITDAN/A
Interest Coverage627.55

Financial Efficiency

Medikit Co.,Ltd. posts a return on equity of 4.30 and a return on invested capital of 3.75.

Return on Equity (ROE)4.30
Return on Assets (ROA)3.29
Return on Invested Capital (ROIC)3.75
Return on Capital Employed (ROCE)4.31
Revenue Per EmployeeN/A
Employee CountN/A
Inventory Turnover1.75

Taxes

Over the trailing twelve months, Medikit Co.,Ltd. has paid 628.22M in income taxes, reflecting an effective tax rate of 26.43.

Income Tax628.22M
Effective Tax Rate26.43

Stock Price Statistics

Medikit Co.,Ltd.'s stock has gained approximately 9.38967% over the past 52 weeks. The 50-day moving average sits at 2,877.66, while the 200-day moving average is 2,887.24.

Beta (5Y)N/A
52-Week Price Change9.38967%
50-Day Moving Average2,877.66
200-Day Moving Average2,887.24
Average Volume (20 Days)N/A

Income Statement

Over the trailing twelve months, Medikit Co.,Ltd. generated 11.00B in revenue and converted that into 1.75B in net income, yielding earnings per share of 118.19. EBITDA reached 2.40B, while operating income came in at 2.40B.

Revenue11.00B
Gross Profit4.34B
Operating Income2.40B
Pretax Income2.38B
Net Income1.75B
EBITDA2.40B
EBIT2.40B
Earnings Per Share (EPS)118.19

Balance Sheet

Total book value stands at 41.47B, with working capital of 27.77B providing operational flexibility.

Cash & Cash Equivalents22.84B
Total DebtN/A
Net Debt-22.84B
Equity (Book Value)41.47B
Book Value Per Share2,802.43
Working Capital27.77B

Margins

Medikit Co.,Ltd. operates with a gross margin of 39.45, reflecting its pricing power and cost economics. The operating margin of 21.82 and net profit margin of 15.89 provide insight into operational efficiency.

Gross Margin39.45
Operating Margin21.82
Pretax Margin21.60
Profit Margin15.89
EBITDA Margin21.82

Stock Splits

Medikit Co.,Ltd.'s most recent stock split took place on March 30, 2020 with a 1:2 split ratio.

Last Split Date3/30/2020
Split Ratio1:2

Scores

Medikit Co.,Ltd. posts an Altman Z-Score of 5.69, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score5.69